| __timestamp | Alpine Immune Sciences, Inc. | BeiGene, Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 21862000 |
| Thursday, January 1, 2015 | 16054000 | 58250000000 |
| Friday, January 1, 2016 | 23316000 | 98033000 |
| Sunday, January 1, 2017 | 10626000 | 269018000 |
| Monday, January 1, 2018 | 28970000 | 679005000 |
| Tuesday, January 1, 2019 | 35847000 | 927338000 |
| Wednesday, January 1, 2020 | 27185000 | 1294877000 |
| Friday, January 1, 2021 | 58742000 | 1459239000 |
| Saturday, January 1, 2022 | 70243000 | 1640508000 |
| Sunday, January 1, 2023 | 80904000 | 1778594000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BeiGene, Ltd. and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, BeiGene's R&D expenses surged by an astounding 8,000%, reflecting its aggressive expansion and dedication to pioneering cancer therapies. In contrast, Alpine Immune Sciences exhibited a more modest growth of approximately 560% in R&D spending, focusing on autoimmune and inflammatory diseases. This divergence highlights the strategic differences between the two companies, with BeiGene's spending peaking at nearly 1.8 billion in 2023, dwarfing Alpine's 81 million. As these companies continue to innovate, their R&D investments will likely shape the future of medical breakthroughs.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
R&D Insights: How BeiGene, Ltd. and MannKind Corporation Allocate Funds
BeiGene, Ltd. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.